Caretaker Medical and Mespere LifeSciences partner to deliver integrated Cerebral Oximetry and Continuous Non-Invasive Blood Pressure in a single platform
-CHARLOTTESVILLE, VA and WATERLOO, CANADA April 10, 2019
Caretaker Medical, manufacturer of the Wireless Caretaker® Finger-Cuff Patient Monitoring Platform for Continuous Non-Invasive Blood Pressure (“CNIBP”) & Wireless Vital Signs, and Mespere LifeSciences, an innovator in breakthrough technology for non-invasive cardiac and cerebral hemodynamic monitoring systems today announced a partnership that integrates wireless CNIBP, Cerebral Oximetry, and other critical non-invasive hemodynamic measurements in a single monitoring platform.
Caretaker’s wireless vital signs, CNIBP, and waveform data can be displayed together with Cerebral Oximetry, Cardiac Output, Blood Volume, and other parameters Mespere’s NeurOs monitoring platform, providing clinicians with a single realtime view of a patient’s comprehensive hemodynamic condition.
Mespere’s NeurOs Cerebral Oximetry is the only Depth Resolved cerebral oximeter in the market, which can specifically target cortical tissue through scalp & skull and provide reliable measurement of the hemodynamics of brain tissues.
“Combining Caretaker’s continuous “beat by beat” Blood Pressure and wireless vital signs with Mespere’s Cerebral Oximetry and Blood Volume Index parameters in a non-invasive, affordable platform will allow clinicians to have better decision-making tools at all points of care, not just the ICU,” said Jeff Pompeo, Caretaker Medical’s President and CEO. “Continuous Blood Pressure is a far better measure of core hemodynamic trending that typical intermittent BP Cuffs, and Cerebral Oximetry is a leading indicator of brain function. Together these parameters can provide a more comprehensive view of true hemodynamic health and potentially yield an earlier indication of patient deterioration.”
“Monitoring cerebral hemodynamic and arterial pressure simultaneously may potentially allow physicians to access cerebral autoregulation and cerebral hypertension in real time. I am very excited about the collaboration with Caretaker Medical,” said Dr. Xuefeng Cheng, Mespere LifeSciences’ CEO.
Both the Caretaker wireless CNIBP and Vital Signs Monitor and the Mespere NeurOs are FDA Cleared and CE-Mark certified, and available immediately. For more information or to schedule a demonstration, contact Caretaker Medical or Mespere LifeSciences.
About Caretaker Medical
Caretaker Medical is a Charlottesville, Virginia based wireless medical device firm focused on developing affordable, innovative, wireless patient monitoring solutions that improve outcomes, increase clinician productivity, and maximize patient compliance without compromising patient comfort.
The wearable Caretaker4® monitor enables uninterrupted wire-free and electrode-free real-time vital signs monitoring throughout the full continuum of care, from clinic and hospital, to patient transport, and home monitoring after discharge. Using only a comfortable, low-pressure finger cuff, Caretaker’s patented Pulse Decomposition Analysis technology non-invasively measures continuous Beat-by-Beat blood pressure, Heart Rate, and Respiration Rate for remote display on the Caretaker® Tablet App and other Remote Data Displays. The Caretaker cNIBP technology delivers “ICU Quality” continuous measurements without intrusive catheters or cumbersome wires, giving clinicians the ability to recognize developing cardiopulmonary trends earlier with more lead time for intervention while providing a much more comprehensive view of a patient’s hemodynamic status.
More information is available at www.caretakermedical.net
About Mespere LifeSciences
Mespere LifeSciences is a Canadian high-tech medical device company focused on providing better solutions for critical clinical needs by reducing the need for invasive clinical procedures. Mespere has developed multiple breakthrough products such as the world’s first non-invasive central venous pressure monitor, jugular venous oximetry, and depth resolved cerebral oximetry etc. Mespere aims to provide connected multi-organ hemodynamic monitoring solutions which are more cost effective, easier to use, safer, painless, all while improving patient outcomes.
The significant advantages of Mesepre NeurOs Cerebral Oximetry system versus other cerebral oximeters are:
- Highest absolute trending accuracy of +/-1.5%
- The only Depth Resolved cerebral oximeter which greatly improves the specificity in cortical tissue measurement
- The only cerebral oximeter with BVI to monitor tissue vascular filling
- Flexible with portable monitor/computers for various clinical settings
- Reusable sensors with low cost disposables which significantly reduces per patient costs.
More information is available at www.mespere.com